Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CFMS

Conformis (CFMS) Stock Price, News & Analysis

Conformis logo

About Conformis Stock (NASDAQ:CFMS)

Advanced Chart

Key Stats

Today's Range
$2.25
$2.27
50-Day Range
$2.22
$2.26
52-Week Range
$1.05
$7.25
Volume
7,000 shs
Average Volume
99,585 shs
Market Capitalization
$17.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CFMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conformis and its competitors with MarketBeat's FREE daily newsletter.

CFMS Stock News Headlines

Conformis (NASDAQ: CFMS)
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
CFM Investment JSC CFM
Computer Forms (Malaysia) Bhd (CFMS)
Durham medtech completes acquisition of public company
See More Headlines

CFMS Stock Analysis - Frequently Asked Questions

Conformis, Inc. (NASDAQ:CFMS) posted its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported ($1.75) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($1.75). The medical instruments supplier earned $14.25 million during the quarter, compared to analyst estimates of $14.08 million. Conformis had a negative trailing twelve-month return on equity of 86.46% and a negative net margin of 72.72%.
Read the conference call transcript
.

Shares of Conformis reverse split on the morning of Wednesday, November 9th 2022.The 1-25 reverse split was announced on Wednesday, November 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Conformis (CFMS) raised $135 million in an initial public offering on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Conformis investors own include Meta Platforms (META), Micron Technology (MU), NIO (NIO), NVIDIA (NVDA), Alibaba Group (BABA), QUALCOMM (QCOM) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/03/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:CFMS
Employees
295
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.47 million
Pretax Margin
-72.63%

Debt

Sales & Book Value

Annual Sales
$57.06 million
Price / Cash Flow
N/A
Book Value
$4.07 per share
Price / Book
0.56

Miscellaneous

Free Float
7,579,000
Market Cap
$17.80 million
Optionable
Not Optionable
Beta
1.39

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:CFMS) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners